Home › Studies › PRJNA1469454
PRJNA1469454 SRP702920

Gut metagenome, melanoma on immunotherapy, 2 timepoints

Human gut metagenome from melanoma patients collected at two timepoints

32 fecal samples from melanoma patients (24 adult, 8 elderly), collected before and 3 months after starting immune checkpoint inhibitor therapy, in a longitudinal design. machine-written summary

32 samples · 64 runs · RU · Adult · 2026 · 4.44 Gbp / sample

Sources
✓Sequence archive 320✓Abstract / description 64–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive320 sample values (age, collection date, country, latitude, location locality, location region, longitude, sex)
✓ Abstract / description64 sample values (health condition, health condition detail)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

Non-antibiotic pharmaceutical given as the study intervention (metformin · population other_cancer · Immune checkpoint inhibitor immunotherapy, pre- vs 3-month post-treatment

“response to immune checkpoint inhibitor (ICI) immunotherapy” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult24
elderly8
Condition
other_cancer32
Sex
female18
male14
Country
RU32
Body site
primary32
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 32 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.44 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

16 of 16 people sampled more than once (32 samples; median 2, up to 2 per person). Schedule stated by the source: “prior to treatment initiation and 3 month after treatment onset” (time origin: treatment_start); stated follow-up 3 mo.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category32 100%
country32 100%32
health_condition32 100%32
subject_id32 100%32
age_at_collection_days32 100%32
collection_date32 100%32
detailed_location32 100%
health_condition_detail32 100%32
latitude32 100%32
location_locality32 100%32
location_region32 100%32
longitude32 100%32
sex32 100%32
timepoint_label32 100%32
Details
Archive description

For a longitudinal study of gut microbiome dynamics in response to immune checkpoint inhibitor (ICI) immunotherapy, fecal samples were collected from 16 melanoma patients at two timepoints: prior to treatment initiation and 3 month after treatment onset.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult and elderly by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Human gut metagenome from melanoma”
  • body site study.description · “longitudinal study of gut microbiome dynamics in”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage sample.attr.age · “62 (n=14/32)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN60358217age_at_collection_days29220.0R10.70sample.attr.age80
SAMN60358217collection_date2025R10.90biosample.attribute:collection_date2025
SAMN60358217countryRUR10.90sample.attr.geo_loc_nameRussia: Moscow
SAMN60358217health_conditionother_cancerR40.50study.description16 melanoma patients
SAMN60358217health_condition_detailmelanomaR40.50study.descriptionmelanoma patients
SAMN60358217latitude55.4500R10.90biosample.attribute:lat_lon55.45 N 37.37 E
SAMN60358217location_localityMoscowR10.85biosample.attribute:geo_loc_nameRussia: Moscow
SAMN60358217location_regionMoscowR10.85biosample.attribute:geo_loc_nameRussia: Moscow
SAMN60358217longitude37.3700R10.90biosample.attribute:lat_lon55.45 N 37.37 E
SAMN60358217sexmaleR10.90sample.attr.sexmale
SAMN60358217subject_idLong_1R10.70sample.name_rule:aliasLong_1_1
SAMN60358217timepoint_label1R10.85sample.attr.time_point1
Sequencing

64 runs over 32 samples · mean 2.30 Gbp per run (median 3.02 Gbp, total 147.45 Gbp; 64 runs with a base count) · layout PAIRED 32, SINGLE 32 · platform ILLUMINA 32, OXFORD_NANOPORE 32 · models NextSeq 1000 (32), PromethION (32) · 0% of runs with a Sandpiper profile · first public 2026-09-01

Authors (0)

No author record.

Downloads

PRJNA1469454.csv.gz (1.8 KB) · parquet (71.7 KB) — all 32 samples, every field with route and confidence · PRJNA1469454_determinations.csv.gz (3.1 KB) — 384 evidence rows

Samples (32 · every field this project has values for · hover a cell for its source)
Loading the sample table…